World Thrombosis Day Campaign Welcomes New Global Thrombosis Experts to Scientific Steering Committee

Going into its seventh year, the World Thrombosis Day campaign is guided by a Steering Committee of international medical experts in the fields of hematology, thrombosis and hemostasis, vascular and general internal medicine, and public health under the leadership of Chair Beverley Hunt, OBE, of the United Kingdom. 

Following a competitive application and review process, the subsequent six new members begin their term as of January 2020:

• Stefano Barco (Germany)
• Lana Castellucci (Canada)
• Gabriela Cesarman-Maus (Mexico)
• Erich De Paula (Brazil)
• Mert Dumantepe (Turkey)
• Maria Cecilia Guillermo (Uruguay)

“We are proud to welcome such a respected and accomplished group of experts to the World Thrombosis Day Steering Committee,” said Hunt.  “As a global awareness campaign, we place a high value on diverse representation across all regions of the world, and this is well-represented in the geographic locations of our new committee members. We look forward to working together to further the campaign’s mission and help save lives.” 

The incoming Steering Committee members will serve a two-year term from 2020-2022 with the option for renewal. They are joined by the existing Steering Committee members, comprising of a 14-person total global Steering Committee.

Following the ISTH’s formal committee rotation pattern, the following individuals recently rotated off the World Thrombosis Day Steering Committee after more than five years of service to the campaign: Pantep Angchaisuksiri (Thailand), Alicia Blanco (Argentina), Elaine Hylek (USA), Lord Ajay Kakkar (UK), Jeffrey Weitz (Canada) and Aaron Wendelboe (USA).

For more information about the incoming Steering Committee members and their professional backgrounds, visit www.worldthrombosisday.org/about/founders/.

+++

About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly’s global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Unrestricted corporate grants to help support WTD come from founding global partner Bayer HealthCare; global partners are Bristol-Myers Squibb/Pfizer Alliance, Daiichi Sankyo, Janssen and Portola Pharmaceuticals. Visit www.worldthrombosisday.org for more information.

About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with 5,000 clinicians, researchers and educators working together to improve the lives of patients in more than 93 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs such as its Core Curriculum, research activities; meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.

Media Contact
Sam Perry, Campaign Manager
International Society on Thrombosis and Haemostasis
+1 919-929-3807
Sam_Perry@isth.org